Construction of a new plant for the production of intravenous solutionsis being planned by Hungarian company Human, which also announced that its wholesale trading subsidiary will open new offices and a warehouse center, according to MTI Econews.
The new solutions plant, construction of which was scheduled to start last month with completion due early next year, will cost 2 billion forint ($10.4 million). Human's older solutions plant will cease production when the new plant starts operation. The new offices and warehouse will cost the firm 110 million forint. Human has prepared a business plan which includes a 50% increase in its turnover and a doubling of profits by end-1999. Last year, it recorded a gross profit of 496 million forint, and consolidated gross profit of 206 million forint in the first quarter of this year.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze